Burning Rock Biotech Q2 EPS $(0.20) Down From $(0.10) YoY, Sales $19.862M Down From $20.737M YoY

Benzinga Newsdesk www.benzinga.com Negative 96.5%

Neg 96.5% Neu 0% Pos 0%

Burning Rock Biotech (NASDAQ:BNR) reported quarterly losses of $(0.20) per share. This is a 100 percent decrease over losses of $(0.10) per share from the same period last year. The company reported $19.862 million in sales this quarter. This is a 4.22 percent decrease over sales of $20.737 million the same period last year.